<DOC>
	<DOCNO>NCT00838812</DOCNO>
	<brief_summary>The purpose study determine safety efficacy association tretinoin clindamycin phosphate treatment acne vulgaris mild moderate .</brief_summary>
	<brief_title>Safety Efficacy Study Association Between Tretinoin Clindamycin Treatment Acne Mild Moderate</brief_title>
	<detailed_description />
	<mesh_term>Acne Vulgaris</mesh_term>
	<mesh_term>Clindamycin</mesh_term>
	<mesh_term>Clindamycin palmitate</mesh_term>
	<mesh_term>Clindamycin phosphate</mesh_term>
	<mesh_term>Tretinoin</mesh_term>
	<criteria>Individuals sex age great equal 12 year Subjects diagnose acne vulgaris face , except nasal area , range mild moderate , following requirement . Mild acne = presence few 20 comedo less 15 lesion , inflammatory lesion total less 30 injury . Moderate acne = presence 20 100 comedo 15 50 inflamatory lesion total 30 125 lesion , lesion small nodule 5,0 mm . Ensure exist injury submit treatment acne , topical systemic , within last 30 day . Be able properly follow determination Protocol . Has provide write voluntary consent participate study , sign informed consent , subject procedure . Under 18 year old , accompanied legal guardian process obtain informed consent . Be mentally able provide consent fulfilling requirement study . Pregnant woman period lactation . Women childbearing age sexual activity use safe contraceptive method , oral contraceptive , implantable , injectable intrauterine , introduce least 120 day . Women use oral contraceptive contain hormone combination acetate ciprosterone etinolestradiol , association drospirenone ethinyl estradiol , desogestrel . Clinical evidence history immunodeficiency . Any use immunosuppressive drug and/or immunomodulating past 3 month , topical systemic . Concurrent use fotossentetizadores , neuromuscular blocker , medication exacerbate acne , blocker ( filter ) solar alcoholic vehicle , spironolactone , flutamide zinc salt . Prior use systemic retinoid . Presence acne medication and/or cosmetic . History systemic metabolic disorder interfere integrity skin . History inflammatory disease , intestinal regional enteritis and/or symptom similar . History joy component formula ( active principle carrier ) . History abuse alcohol and/or illegal drug . History nonadherence medical treatment earlier . Any clinical observation make investigator prohibits participation study subject .</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2010</verification_date>
	<keyword>clindamycin</keyword>
	<keyword>tretinoin</keyword>
	<keyword>acne vulgaris</keyword>
	<keyword>Acne vulgaris mild moderate</keyword>
</DOC>